Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Daridorexant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 49,323Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nxera Pharma Enrolls 1st Insomnia Patient in Ph 3 Trial
    Nxera Pharma Enrolls 1st Insomnia Patient in Ph 3 Trial

    04 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/05/2991987/0/en/Nxera-Pharma-Enrolls-First-Insomnia-Patient-in-its-Phase-3-Clinical-Trial-of-Daridorexant-in-South-Korea.html

    GLOBENEWSWIRE
    04 Dec 2024
    Share Share
    Nxera Pharma's QUVIVIQ Approved In Japan For Insomnia
    Nxera Pharma's QUVIVIQ Approved In Japan For Insomnia

    23 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/24/2951862/0/en/Nxera-Pharma-Receives-Approval-of-QUVIVIQ-daridorexant-25-and-50-mg-in-Japan-for-the-Treatment-of-Insomnia.html

    GLOBENEWSWIRE
    23 Sep 2024
    Share Share
    New data with daridorexant to be presented at SLEEP 2024
    New data with daridorexant to be presented at SLEEP 2024

    03 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/03/2891892/0/en/New-data-with-daridorexant-to-be-presented-at-SLEEP-2024.html

    GLOBENEWSWIRE
    03 Jun 2024
    Share Share
    Sosei Announces Submission of New Drug Application in Japan for Daridorexant
    Sosei Announces Submission of New Drug Application in Japan for Daridorexant

    31 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/31/2769844/0/en/Sosei-Heptares-Announces-Submission-of-New-Drug-Application-in-Japan-for-Daridorexant-ACT-541468-a-Dual-Orexin-Receptor-Antagonist-for-the-Treatment-of-Insomnia.html

    GLOBENEWSWIRE
    31 Oct 2023
    Share Share
    Idorsia announces its insomnia medication, QUVIVIQ, is now covered by CVS
    Idorsia announces its insomnia medication, QUVIVIQ, is now covered by CVS

    10 Jul 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/idorsia-announces-its-insomnia-medication-quviviq-daridorexant-is-now-covered-by-cvs-301872158.html

    PR NEWSWIRE
    10 Jul 2023
    Share Share
    Idorsia launches QUVIVIQ (daridorexant) in Switzerland
    Idorsia launches QUVIVIQ (daridorexant) in Switzerland

    12 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/12/2685940/0/en/Idorsia-launches-QUVIVIQ-daridorexant-in-Switzerland-a-first-in-class-treatment-for-chronic-insomnia-disorder-to-improve-both-nighttime-symptoms-and-daytime-functioning.html

    GLOBENEWSWIRE
    12 Jun 2023
    Share Share